申请人:Mammen Mathai
公开号:US20090023777A1
公开(公告)日:2009-01-22
This invention provides 4-amino-1-benzylpiperidine and related compounds and pharmaceutically acceptable salts thereof which are useful as muscarinic receptor antagonists. This invention also provides pharmaceutical compositions containing such compounds; processes and intermediates useful for preparing such compounds; and methods for treating disease conditions mediated by muscarinic receptors, such as overactive bladder, irritable bowel syndrome, asthma and chronic obstructive pulmonary disease, using such compounds.
本发明提供4-氨基-1-苄基哌啶及其相关化合物和药学上可接受的盐,其作为毒蕈碱受体拮抗剂具有用途。本发明还提供含有这些化合物的制药组合物;用于制备这些化合物的有用中间体和过程;以及使用这些化合物治疗由毒蕈碱受体介导的疾病情况,例如过度活跃的膀胱、肠易激综合征、哮喘和慢性阻塞性肺疾病等的方法。